Mengcheng Shen

1.4k total citations
28 papers, 922 citations indexed

About

Mengcheng Shen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Mengcheng Shen has authored 28 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 7 papers in Surgery. Recurrent topics in Mengcheng Shen's work include Pluripotent Stem Cells Research (6 papers), Congenital heart defects research (6 papers) and Cardiac Fibrosis and Remodeling (6 papers). Mengcheng Shen is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), Congenital heart defects research (6 papers) and Cardiac Fibrosis and Remodeling (6 papers). Mengcheng Shen collaborates with scholars based in United States, Canada and China. Mengcheng Shen's co-authors include Zamaneh Kassiri, Mei Hu, Joseph C. Wu, Sayantan Jana, Gavin Y. Oudit, Ratnadeep Basu, Fan Dong, Hao Zhang, Carlos Fernández-Patrón and Mingxia Gu and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Mengcheng Shen

28 papers receiving 917 citations

Peers

Mengcheng Shen
Nadine J.A. Mattheij Netherlands
Javier Barallobre‐Barreiro United Kingdom
Xingbo Xu Germany
Kaori Ihida‐Stansbury United States
Pia Leppänen Finland
Sarah L. Tressel United States
Janet K. Lighthouse United States
Tsuyoshi Tachibana Japan
Marieke Rienks Netherlands
Robert Wirka United States
Nadine J.A. Mattheij Netherlands
Mengcheng Shen
Citations per year, relative to Mengcheng Shen Mengcheng Shen (= 1×) peers Nadine J.A. Mattheij

Countries citing papers authored by Mengcheng Shen

Since Specialization
Citations

This map shows the geographic impact of Mengcheng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengcheng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengcheng Shen more than expected).

Fields of papers citing papers by Mengcheng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengcheng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengcheng Shen. The network helps show where Mengcheng Shen may publish in the future.

Co-authorship network of co-authors of Mengcheng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Mengcheng Shen. A scholar is included among the top collaborators of Mengcheng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengcheng Shen. Mengcheng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chunying, Mengcheng Shen, Yanxia Liu, et al.. (2024). CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity. Cell stem cell. 31(12). 1760–1776.e9. 13 indexed citations
2.
Li, Zhonghao, Wei Wu, Qiushi Li, et al.. (2024). BCL6B-dependent suppression of ETV2 hampers endothelial cell differentiation. Stem Cell Research & Therapy. 15(1). 226–226. 4 indexed citations
3.
Liu, Chun, Mengcheng Shen, Wilson Lek Wen Tan, et al.. (2023). Statins improve endothelial function via suppression of epigenetic-driven EndMT. Nature Cardiovascular Research. 2(5). 467–485. 49 indexed citations
4.
Yang, Hao, et al.. (2023). Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Research & Therapy. 14(1). 228–228. 22 indexed citations
5.
Shen, Mengcheng, Rui Zhao, Li Li, et al.. (2023). Protocol to generate cardiac pericytes from human induced pluripotent stem cells. STAR Protocols. 4(2). 102256–102256. 2 indexed citations
6.
Wu, Yiyang, Mengcheng Shen, Sophia Zhang, et al.. (2023). Studying Long QT Syndrome Caused by NAA10 Genetic Variants Using Patient-Derived Induced Pluripotent Stem Cells. Circulation. 148(20). 1598–1601. 9 indexed citations
7.
Zhao, Rui, Gema Mondéjar‐Parreño, Dong Li, Mengcheng Shen, & Joseph C. Wu. (2022). Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Journal of Visualized Experiments. 5 indexed citations
8.
Ameen, Mohamed, Laksshman Sundaram, Mengcheng Shen, et al.. (2022). Integrative single-cell analysis of cardiogenesis identifies developmental trajectories and non-coding mutations in congenital heart disease. Cell. 185(26). 4937–4953.e23. 46 indexed citations
9.
Shen, Mengcheng, Chun Liu, & Joseph C. Wu. (2022). Generation of Embryonic Origin-Specific Vascular Smooth Muscle Cells from Human Induced Pluripotent Stem Cells. Methods in molecular biology. 2429. 233–246. 9 indexed citations
10.
Hu, Mei, Sayantan Jana, Faqi Wang, et al.. (2021). Loss of TIMP4 (Tissue Inhibitor of Metalloproteinase 4) Promotes Atherosclerotic Plaque Deposition in the Abdominal Aorta Despite Suppressed Plasma Cholesterol Levels. Arteriosclerosis Thrombosis and Vascular Biology. 41(6). 1874–1889. 12 indexed citations
11.
Zhao, Rui, Mengcheng Shen, Chelsea Lee, et al.. (2021). Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying TNNI3 mutations. Stem Cell Research. 57. 102597–102597. 2 indexed citations
12.
Zhang, Hao, Mengcheng Shen, & Joseph C. Wu. (2020). Generation of Quiescent Cardiac Fibroblasts Derived from Human Induced Pluripotent Stem Cells. Methods in molecular biology. 2454. 109–115. 13 indexed citations
13.
Wang, Wang, Mengcheng Shen, Conrad Fischer, et al.. (2019). Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs. Proceedings of the National Academy of Sciences. 116(26). 13006–13015. 46 indexed citations
14.
Jana, Sayantan, Mei Hu, Mengcheng Shen, & Zamaneh Kassiri. (2019). Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm. Experimental & Molecular Medicine. 51(12). 1–15. 144 indexed citations
15.
Zhang, Hao, Lei Tian, Mengcheng Shen, et al.. (2019). Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis. Circulation Research. 125(5). 552–566. 110 indexed citations
16.
Zhabyeyev, Pavel, Subhash K. Das, Ratnadeep Basu, et al.. (2018). TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease. American Journal of Physiology-Heart and Circulatory Physiology. 314(5). H978–H990. 24 indexed citations
17.
Shen, Mengcheng, Jude S. Morton, Sandra T. Davidge, & Zamaneh Kassiri. (2016). Loss of smooth muscle cell disintegrin and metalloproteinase 17 transiently suppresses angiotensin II-induced hypertension and end-organ damage. Journal of Molecular and Cellular Cardiology. 103. 11–21. 35 indexed citations
18.
Dong, Fan, Abhijit Takawale, Mengcheng Shen, et al.. (2016). A Disintegrin and Metalloprotease-17 Regulates Pressure Overload–Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1. Hypertension. 68(4). 937–948. 36 indexed citations
19.
Zhang, Pu, Mengcheng Shen, Carlos Fernández-Patrón, & Zamaneh Kassiri. (2015). ADAMs family and relatives in cardiovascular physiology and pathology. Journal of Molecular and Cellular Cardiology. 93. 186–199. 52 indexed citations
20.
Lee, Jiwon, Mengcheng Shen, Nirmal Parajuli, et al.. (2014). Gender-dependent aortic remodelling in patients with bicuspid aortic valve-associated thoracic aortic aneurysm. Journal of Molecular Medicine. 92(9). 939–949. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadine J.A. Mattheij Breakdown of academic impact, for papers by Javier Barallobre‐Barreiro Breakdown of academic impact, for papers by Xingbo Xu Breakdown of academic impact, for papers by Kaori Ihida‐Stansbury Breakdown of academic impact, for papers by Pia Leppänen Breakdown of academic impact, for papers by Sarah L. Tressel Breakdown of academic impact, for papers by Janet K. Lighthouse Breakdown of academic impact, for papers by Tsuyoshi Tachibana Breakdown of academic impact, for papers by Marieke Rienks Breakdown of academic impact, for papers by Robert Wirka
Rankless by CCL
2026